Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environment
Pharmacoepidemiology and Drug Safety · 2024
DOI: 10.1002/pds.5820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Ashish Rai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Pharmacoepidemiology, United States Food and Drug Administration. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: U.S. Food and Drug Administration.
Abstract (Originalsprache)
Purpose
Our objective is to describe how the U.S. Food and Drug Administration (FDA)'s Sentinel System implements best practices to ensure trust in drug safety studies using real‐world data from disparate sources.
Methods
We present a stepwise schematic for Sentinel's data harmonization, data quality check, query design and implementation, and reporting practices, and describe approaches to enhancing the transparency, reproducibility, and replicability of studies at each step.
Conclusions
Each Sentinel data partner converts its source data into the Sentinel Common Data Model. The transformed data undergoes rigorous quality checks before it can be used for Sentinel queries. The Sentinel Common Data Model framework, data transformation codes for several data sources, and data quality assurance packages are publicly available. Designed to run against the Sentinel Common Data Model, Sentinel's querying system comprises a suite of pre‐tested, parametrizable computer programs that allow users to perform sophisticated descriptive and inferential analysis without having to exchange individual‐level data across sites. Detailed documentation of capabilities of the programs as well as the codes and information required to execute them are publicly available on the Sentinel website. Sentinel also provides public trainings and online resources to facilitate use of its data model and querying system. Its study specifications conform to established reporting frameworks aimed at facilitating reproducibility and replicability of real‐world data studies. Reports from Sentinel queries and associated design and analytic specifications are available for download on the Sentinel website. Sentinel is an example of how real‐world data can be used to generate regulatory‐grade evidence at scale using a transparent, reproducible, and replicable process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
- U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
ORCID-Profile: Ashish Rai, Judith C Maro, Sarah Dutcher
Förderung
- U.S. Food and Drug Administration
Zitieren
APA
Rai, A., Maro, J. C., Dutcher, S., Bright, P., & Toh, S. (2024). Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environment. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5820
Vancouver
Rai A, Maro JC, Dutcher S, Bright P, Toh S. Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environment. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.5820
BibTeX
@article{Rai2024,
author = {Rai, Ashish and Maro, Judith C and Dutcher, Sarah and Bright, Patricia and Toh, Sengwee},
title = {Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environment},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
doi = {10.1002/pds.5820}
}
EUVIMED